Among the first prenatal appointments many women look forward to — and feel some anxiety about — is the nuchal translucency scan, typically performed between 11 and 14 weeks of pregnancy. For women pregnant after 35, this scan is often paired with additional screening discussions, which can make it feel like a bigger milestone than it might otherwise be. Understanding what the scan actually measures can help set realistic expectations going in.
Nuchal translucency (NT) screening is an ultrasound measurement of the fluid-filled space at the back of a developing baby’s neck. According to March of Dimes, this measurement, often combined with maternal blood tests, is used to help estimate the likelihood of certain chromosomal conditions, most notably Down syndrome (trisomy 21), as well as trisomy 18 and 13. The scan can sometimes also reveal other structural findings worth noting at this early stage of pregnancy, such as very early indications of certain heart or physical developmental patterns, though the primary purpose of NT measurement specifically is chromosomal risk estimation rather than a full anatomical survey, which typically happens later, around 18 to 22 weeks.
What Research Shows About NT Screening and Age
Maternal age is one of several factors used in calculating the overall risk estimate from NT screening, since the likelihood of certain chromosomal conditions increases with maternal age. This is why women over 35 are sometimes given a numerically higher combined risk score even with a normal NT measurement — age is factored into the calculation alongside the ultrasound findings and blood work results, not used as a standalone predictor.
What the Scan Involves
The NT scan itself is a standard ultrasound, performed either abdominally or, in some cases, transvaginally for better imaging depending on the position of the pregnancy at the time of the scan. A sonographer measures the nuchal fold thickness, and this measurement, combined with maternal age and sometimes blood test results (a combination often referred to as first-trimester combined screening), generates a risk estimate rather than a diagnosis.
Screening vs. Diagnostic Testing
It’s worth being clear that NT screening is a screening test, not a diagnostic one. It estimates probability rather than confirming or ruling out a condition. Women who receive a higher-risk result are typically offered diagnostic testing options, such as chorionic villus sampling (CVS) or amniocentesis, or noninvasive prenatal testing (NIPT), for more definitive information. This is similar to the distinction discussed in prenatal genetic testing options after 35, where screening and diagnostic tests serve different purposes.
Interpreting Results Without Overreacting
Receiving a “higher risk” result from NT screening can understandably feel alarming, but it’s important to remember that most women who receive this result go on to have chromosomally typical babies. The result is a statistical probability, not a diagnosis, and genetic counselors are often available to help interpret results and discuss next steps in a way that reflects actual risk rather than worst-case assumptions. Many hospitals and clinics offer genetic counseling as a standard part of this process, particularly for women over 35.
Making Decisions About Follow-Up Testing
Whether to pursue additional diagnostic testing after an NT scan is a personal decision that depends on individual values, the specific risk estimate, and what a woman or couple would do with additional information. There is no universally “right” choice here — some women prefer as much information as possible, while others are comfortable proceeding with screening results alone. A genetic counselor or OB/GYN can walk through the options without pressure toward any particular decision.
Preparing for the Appointment
Because NT screening is often the first significant prenatal screening appointment, some women find it helpful to know what to expect beforehand. The scan itself typically takes 20 to 45 minutes, and depending on the position of the pregnancy, the sonographer may need to reposition or ask you to move to get a clear view of the nuchal fold. If bloodwork is part of the combined screening, this is sometimes done on the same day or scheduled separately, depending on the clinic’s protocol.
It’s common to feel a mix of excitement and anxiety heading into this appointment, particularly for women who are also processing what it means to be pregnant after 35 in a culture that sometimes uses alarmist language around this. Bringing a support person, writing down questions in advance, and asking the sonographer or provider to walk through results in plain language afterward are all reasonable ways to approach the appointment. Many clinics are accustomed to walking patients through what a risk score actually means before they leave, though it’s also fine to ask for this explicitly if it isn’t offered.
What Happens After the Scan
Results from combined first-trimester screening, when blood work is involved, sometimes take a few days to return, whereas the ultrasound measurement itself is often available immediately. If results indicate a higher-risk estimate, a follow-up call or appointment with a genetic counselor is typically scheduled promptly to discuss next steps and options, rather than leaving results to be delivered without context.
Coping With the Wait for Results
The days between the scan and receiving combined results can feel tense, particularly for women who have already spent time and emotional energy trying to conceive. Some women find it helpful to plan a distracting activity for the waiting period, or to designate one support person to process the wait with, rather than researching every possible outcome online, which can amplify anxiety around statistically unlikely scenarios.
Frequently Asked Questions
Is NT screening required for pregnancies after 35?
It’s not required, but it’s commonly offered and discussed, particularly for women over 35, as part of first-trimester prenatal care options.
Does a higher NT measurement mean something is definitely wrong?
No. NT screening provides a risk estimate, not a diagnosis. Many pregnancies with a higher-risk result still result in a chromosomally typical baby, and follow-up testing can provide more definitive information if desired.
What’s the difference between NT screening and NIPT?
NT screening is an ultrasound-based measurement often combined with blood work, while NIPT (noninvasive prenatal testing) analyzes fetal DNA fragments in maternal blood. Both are screening tools, and providers can discuss which combination makes sense for an individual situation.
Can I decline NT screening?
Yes. Prenatal screening is optional, and some women choose not to pursue it. This is a personal decision that can be discussed openly with your healthcare provider.
Key Takeaways
- Nuchal translucency screening measures fluid at the back of the developing baby’s neck and helps estimate, not diagnose, chromosomal condition risk.
- Maternal age is factored into the overall risk calculation, which is part of why women over 35 may see higher numerical risk estimates even with normal scan results.
- A higher-risk result does not confirm a chromosomal condition; diagnostic testing options exist for those who want more definitive information.
- Genetic counseling can help interpret results and clarify next steps in a way that reflects actual statistical risk.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.